Titan Pharmaceuticals, Inc.
TTNP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,931 | $6,204 | $10,479 | $40,754 |
| - Cash | $2,831 | $6,760 | $2,937 | $6,037 |
| + Debt | $0 | $565 | $187 | $299 |
| Enterprise Value | $100 | $9 | $7,729 | $35,016 |
| Revenue | $0 | $1 | $60 | $1,526 |
| % Growth | -100% | -98.3% | -96.1% | – |
| Gross Profit | -$5 | $1 | -$136 | $1,327 |
| % Margin | – | 100% | -226.7% | 87% |
| EBITDA | -$4,701 | -$7,165 | -$10,039 | -$9,133 |
| % Margin | – | -716,500% | -16,731.7% | -598.5% |
| Net Income | -$4,706 | -$5,569 | -$10,177 | -$8,114 |
| % Margin | – | -556,900% | -16,961.7% | -531.7% |
| EPS Diluted | -5.23 | -7.41 | -15.15 | -4.06 |
| % Growth | 29.4% | 51.1% | -273.2% | – |
| Operating Cash Flow | -$3,880 | -$7,092 | -$8,183 | -$7,899 |
| Capital Expenditures | $0 | -$2 | $0 | -$23 |
| Free Cash Flow | -$3,880 | -$7,094 | -$8,183 | -$7,922 |